Clinical Trial Update: Carfilzomib, Cyclophosphamide and Dexamethasone In Newly Diagnosed Multiple Myeloma Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating carfilzomib, cyclophosphamide, and dexamethasone in newly diagnosed multiple myeloma patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• carfilzomib, cyclophosphamide and dexamethasone

Snippet

Sponsor: European Myeloma Network B.V. | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED